| CPC C12N 5/0693 (2013.01) [A61K 39/39558 (2013.01); C07K 16/2818 (2013.01); C12N 5/0636 (2013.01); G01N 33/5011 (2013.01); G01N 33/5047 (2013.01); G01N 33/57484 (2013.01); A61K 2039/505 (2013.01); G01N 2800/50 (2013.01)] | 17 Claims |
|
1. A method for identifying a candidate agent as an immunotherapeutic effective to activate tumor-infiltrating immune cells in a patient's tumor, the method comprising:
obtaining or providing a tumor tissue sample comprising stromal and immune cells obtained from the patient's tumor;
culturing the tumor tissue sample in a gel with an air-liquid interface such that a patient specific organoid (PDO) with stromal and immune cell elements is formed;
contacting the PDO with the candidate agent for a period of time sufficient to modulate tumor-infiltrating immune cell activity;
determining an effect of the candidate agent on tumor-infiltrating immune cell activity; and
identifying the candidate agent as an immunotherapeutic effective to activate tumor-infiltrating immune cells in the patient's tumor when the tumor-infiltrating immune cell activity is increased relative to a control PDO that is not contacted with the candidate agent.
|